StonvexLoading…
StonvexStonvexStonvexCore line items from BRLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|
Revenue | $29.10M | $31.38M |
Operating Income | $-20.40M | $-19.95M |
Net Income | $-25.33M | $-27.48M |
EPS (Diluted) | $-1.25 | $-2.56 |
Total Assets | $60.01M | $65.79M |
Total Liabilities | $60.70M | $87.13M |
Cash & Equivalents | $652.97K | $7.62M |
Free Cash Flow OCF − CapEx | $-16.74M | $-22.47M |
Shares Outstanding | 21.38M | 10.75M |